These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 12085695)
61. Cardiac and intestinal natriuretic peptides: insights from genetically modified mice. Kuhn M Peptides; 2005 Jun; 26(6):1078-85. PubMed ID: 15911075 [TBL] [Abstract][Full Text] [Related]
62. Physiologic and pathophysiologic effects of natriuretic peptides and their implications in cardiopulmonary disease. Turk JR J Am Vet Med Assoc; 2000 Jun; 216(12):1970-6. PubMed ID: 10863599 [No Abstract] [Full Text] [Related]
63. B-type natriuretic peptide: from bench to bedside. Adams KF; Mathur VS; Gheorghiade M Am Heart J; 2003 Feb; 145(2 Suppl):S34-46. PubMed ID: 12594450 [No Abstract] [Full Text] [Related]
65. [Recent trends in studies of the etiology of hypertension: New endocrine regulators of blood pressure]. Kita T; Eto T Nihon Rinsho; 2001 May; 59(5):886-91. PubMed ID: 11391987 [TBL] [Abstract][Full Text] [Related]
66. Natriuretic peptides and their therapeutic potential in heart failure treatment: An updated review. Namdari M; Eatemadi A; Negahdari B Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):1-7. PubMed ID: 27755944 [TBL] [Abstract][Full Text] [Related]
67. Natriuretic peptide system in fetal heart and circulation. Walther T; Schultheiss HP; Tschöpe C; Stepan H J Hypertens; 2002 May; 20(5):785-91. PubMed ID: 12011627 [TBL] [Abstract][Full Text] [Related]
68. [Natriuretic peptides: their role in diagnosis and therapy]. Pakuła D; Marek B; Kajdaniuk D; Kos-Kudła B; Borgiel-Marek H; Krysiak R; Gatnar A; Pakuła P Endokrynol Pol; 2007; 58(4):364-74. PubMed ID: 18058731 [TBL] [Abstract][Full Text] [Related]
70. Recent data on the regulation of lipolysis by catecholamines and natriuretic peptides. Lafontan M; Berlan M; Stich V; Crampes F; Rivière D; De Glisezinski I; Sengenes C; Galitzky J Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 1):86-90. PubMed ID: 11994667 [No Abstract] [Full Text] [Related]
71. The paradox of increased natriuretic hormones in congestive heart failure patients: does the endocrine heart also fail in heart failure? Goetze JP; Kastrup J; Rehfeld JF Eur Heart J; 2003 Aug; 24(16):1471-2. PubMed ID: 12919769 [No Abstract] [Full Text] [Related]
72. Measurement and importance of plasma brain natriuretic peptide and related peptides. Sagnella GA Ann Clin Biochem; 2001 Mar; 38(Pt 2):83-93. PubMed ID: 11269760 [No Abstract] [Full Text] [Related]
73. Increased human brain natriuretic peptide in congestive heart failure. Mukoyama M; Nakao K; Saito Y; Ogawa Y; Hosoda K; Suga S; Shirakami G; Jougasaki M; Imura H N Engl J Med; 1990 Sep; 323(11):757-8. PubMed ID: 2143809 [No Abstract] [Full Text] [Related]
74. Guanylyl Cyclase-A Receptor Activation With Natriuretic Propeptides. de Bold AJ JACC Heart Fail; 2015 Sep; 3(9):724. PubMed ID: 26362448 [No Abstract] [Full Text] [Related]
75. Novel neuropeptides in the pathophysiology of heart failure: adrenomedullin and endothelin-1. Petrie MC; McClure SJ; Love MP; McMurray JJ Eur J Heart Fail; 1999 Mar; 1(1):25-9. PubMed ID: 10937975 [TBL] [Abstract][Full Text] [Related]
76. The role of the natriuretic peptides in the cardiovascular system. Suzuki T; Yamazaki T; Yazaki Y Cardiovasc Res; 2001 Aug; 51(3):489-94. PubMed ID: 11476739 [TBL] [Abstract][Full Text] [Related]
80. Is there a common mechanism of benefit for effective treatment of heart failure? Cohn JN Eur J Heart Fail; 1999 Mar; 1(1):31-4. PubMed ID: 10937976 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]